INTERNATIONAL PATENT: ARKGEN BIOSCIONS CO.,LTD., 주식회사 아크젠바이오사이온스 FILES APPLICATION FOR "RANKL MUTANT AND VACCINE COMPOSITION COMPRISING SAME"

GENEVA, Aug. 12 -- ARKGEN BIOSCIONS CO.,LTD. (#402, 582 Daedeok-daero,Yuseong-guDaejeon 34121), 주식회사 아크젠바이오사이온스 (대전광역시유성구대덕대로 582, 402호) filed a patent application (PCT/KR2025/001531) for "RANKL MUTANT AND VACCINE COMPOSITION COMPRISING SAME" on Jan 24, 2025. With publication no. WO/2025/165132, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Invent...